title: Mechanism of PAP I gene induction during hepatocarcinogenesis: clinical implications.
abstract: Pancreatitis-associated protein I (PAP I) is a secretory protein first described as an acute phase reactant during acute pancreatitis. Recently, induction of the PAP I gene was also described in liver during hepatocarcinogenesis. To investigate the molecular mechanisms of this induction, we used constructs carrying progressive deletions of the PAP I promoter fused to the CAT gene. We showed that the silencer conferring tissue specificity on the PAP I gene was inactive in hepatoma cells. Then, in an vitro transcription system, we compared the transcription capacity of nuclear extracts from normal liver and HepG2 cells on constructs containing the silencer. The results confirmed that a trans-acting factor interacting with the PAP I silencer was present in liver cells and absent from hepatoma cells. On the other hand, immunohistochemistry showed that PAP I was expressed in a limited number of transformed hepatocytes. It was concluded that expression of PAP I in hepatocarcinoma occurred through inactivation of its silencer element and was not concomitant in all malignant cells. On that basis, we assayed PAP I in serum from patients with chronic hepatitis, liver cirrhosis or hepatocarcinoma. PAP I levels were normal in chronic active or persistent hepatitis, significantly higher in cirrhosis and strongly elevated in hepatocarcinoma. Because those clinical entities often develop in that sequence, serum PAP I appeared as a potential marker of hepatocarcinoma development.
authors.affiliation: U.315 INSERM, Marseille, France.
authors.forename: N J
authors.initials: NJ
authors.lastname: Dusetti
authors.forename: G
authors.initials: G
authors.lastname: Montalto
authors.forename: E M
authors.initials: EM
authors.lastname: Ortiz
authors.forename: L
authors.initials: L
authors.lastname: Masciotra
authors.forename: J C
authors.initials: JC
authors.lastname: Dagorn
authors.forename: J L
authors.initials: JL
authors.lastname: Iovanna
mesh_terms: D000209:Acute-Phase Proteins / Q000235:genetics / Q000378:metabolism*; D000328:Adult; D000818:Animals; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D006528:Carcinoma, Hepatocellular / Q000097:blood*; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D018983:DNA Footprinting; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D017930:Genes, Reporter; D006521:Hepatitis, Chronic / Q000097:blood*; D006801:Humans; D037181:Lectins, C-Type; D008099:Liver / Q000378:metabolism*; D008103:Liver Cirrhosis / Q000097:blood*; D008113:Liver Neoplasms / Q000097:blood*; D008297:Male; D008875:Middle Aged; D000073718:Pancreatitis-Associated Proteins; D011401:Promoter Regions, Genetic / Q000235:genetics / Q000502:physiology*; D051381:Rats; D017384:Sequence Deletion; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D014407:Tumor Cells, Cultured
chemical_list: D000209:Acute-Phase Proteins; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D037181:Lectins, C-Type; D000073718:Pancreatitis-Associated Proteins; C000612141:REG3A protein, human; C000612144:Reg3b protein, rat; D015500:Chloramphenicol O-Acetyltransferase